1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (7056) 

Invesco European Growth Fund Comments on MorphoSys

November 11, 2013 | About:

MorphoSys (XTER:MOR) is a German biotechnology company with a proprietary technology to develop human antibodies for specific diseases. The company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp.) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Growth Fund’s third quarter 2013 commentary.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus has detected 6 Warning Signs with MorphoSys AG $XTER:MOR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

User Generated Screeners


bpatton23Tech/Divid.
david_r_koenigGurus > $500MM
david_r_koenigROIC - WACC > $500MM Mkt Cap
david_r_koenigM-Score Non-Manipulators > $50
david_r_koenigInvestible Mkt Cap > $500MM
jh007jamesPio - No Valuation
akcapitalSmall Cap
OpExEnhanceFXB1
pbarker46BV growth, Low E10
akcapitalSmall Cap - P/FCF
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK